The Scientist

» FDA and developmental biology

Most Recent

image: How to Track Cell Lineages As They Develop

How to Track Cell Lineages As They Develop

By | December 1, 2016

Sequencing and gene-editing advances make tracing a cells journey throughout development easier than ever.

0 Comments

image: Trump Announces HHS, CMS Picks

Trump Announces HHS, CMS Picks

By | November 30, 2016

President-elect Donald Trump chooses Representative Tom Price to lead the Department of Health and Human Services, Seema Verma to lead the Centers for Medicare and Medicaid Services.

1 Comment

image: Live Imaging Using Light-Sheet Microscopy

Live Imaging Using Light-Sheet Microscopy

By | November 1, 2016

How to make the most of this rapidly developing technique and a look at what's on the horizon

0 Comments

image: Opinion: Aging, Just Another Disease

Opinion: Aging, Just Another Disease

By | November 1, 2016

No longer considered an inevitability, growing older should be and is being treated like a chronic condition. 

26 Comments

An early-stage study of the effectiveness of a lung-cancer vaccine developed by scientists in Cuba could start as early as next month.

0 Comments

image: Bridging a Gap in the Brain

Bridging a Gap in the Brain

By | October 12, 2016

Neuroscientists identify how the left and right hemispheres of the mammalian brain connect during development.

0 Comments

image: Q&A: From FDA to Industry

Q&A: From FDA to Industry

By | September 27, 2016

Among a subset of US Food and Drug Administration regulators who leave the agency, more than half go to work for pharmaceutical companies, researchers report.

1 Comment

image: Further Support for Early-Life Allergen Exposure

Further Support for Early-Life Allergen Exposure

By | September 20, 2016

Egg and peanut consumption during infancy is linked to lower risk of allergy to those foods later in life, according to a meta-analysis.

0 Comments

image: Feds Demand More Clinical Trial Reporting

Feds Demand More Clinical Trial Reporting

By | September 19, 2016

Expanded US Health and Human Services rules will require the results of more human studies to be made public.

1 Comment

image: Conditional FDA Approval for Fatal-Disease Drug

Conditional FDA Approval for Fatal-Disease Drug

By | September 19, 2016

The agency OKs Sarepta Therapeutics’s treatment for Duchenne muscular dystrophy through its accelerated approval pathway, which requires a confirmatory clinical trial.

0 Comments

Popular Now

  1. Antarctica Is Turning Green
  2. How to Tell a Person’s “Brain Age”
  3. Male Fish Borrows Egg to Clone Itself
  4. Life Science Funding Cuts Leaked
    The Nutshell Life Science Funding Cuts Leaked

    According to a document posted online less than a day before the release of the official 2018 budget proposal, the National Institutes of Health could face even deeper cuts than previously suggested by the Trump administration.

AAAS